Literature DB >> 25129617

New insights into the genetics of 5-oxoprolinase deficiency and further evidence that it is a benign biochemical condition.

Eduardo Calpena1, Anup Arunrao Deshpande, Sufin Yap, Akhilesh Kumar, Nigel J Manning, Anand K Bachhawat, Carmen Espinós.   

Abstract

UNLABELLED: Inherited 5-oxoprolinase (OPLAH) deficiency is a rare inborn condition characterised by 5-oxoprolinuria. To date, three OPLAH mutations have been described: p.H870Pfs in a homozygous state, which results in a truncated protein, was reported in two siblings, and two heterozygous missense changes, p.S323R and p.V1089I, were independently identified in two unrelated patients. We describe the clinical context of a young girl who manifested 5-oxoprolinuria together with dusky episodes and who is compound heterozygote for two novel OPLAH variations: p.G860R and p.D1241V. To gain insight into the aetiology of the 5-oxoprolinase deficiency, we investigated the pathogenicity of all the reported missense mutations in the OPLAH gene. A yeast in vivo growth assay revealed that only p.S323R, p.G860R and p.D1241V affected the activity of the enzyme.
CONCLUSION: Taken together, this report further suggests that hereditary 5-oxoprolinase deficiency is a benign biochemical condition caused by mutations in the OPLAH gene, which are transmitted in an autosomal recessive manner, but 5-oxoprolinuria may be a chance association in other disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25129617     DOI: 10.1007/s00431-014-2397-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  Severe hyperhomocysteinaemia and 5-oxoprolinuria secondary to antiproliferative and antimicrobial drug treatment.

Authors:  B Schwahn; G Kameda; R Wessalowski; E Mayatepek
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Persistent 5-oxoprolinuria with normal glutathione synthase and 5-oxoprolinase activities.

Authors:  G J G Ruijter; P E C Mourad-Baars; E Ristoff; W Onkenhout; B J H M Poorthuis
Journal:  J Inherit Metab Dis       Date:  2006-07-08       Impact factor: 4.982

3.  5-Oxoprolinase deficiency associated with severe psychomotor developmental delay, failure to thrive, microcephaly and microcytic anaemia.

Authors:  E Mayatepek; G F Hoffmann; A Larsson; K Becker; H J Bremer
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Deficiency of 5-oxoprolinase in an 8-year-old with developmental delay.

Authors:  F P Bernier; F F Snyder; D R McLeod
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

5.  5-Oxoprolinuria in Heterozygous Patients for 5-Oxoprolinase (OPLAH) Missense Changes.

Authors:  Eduardo Calpena; Mercedes Casado; Dolores Martínez-Rubio; Andrés Nascimento; Jaume Colomer; Eva Gargallo; Angels García-Cazorla; Francesc Palau; Rafael Artuch; Carmen Espinós
Journal:  JIMD Rep       Date:  2012-07-06

6.  5-Oxoprolinuria in patients with and without defects in the gamma-glutamyl cycle.

Authors:  E Mayatepek
Journal:  Eur J Pediatr       Date:  1999-03       Impact factor: 3.183

7.  5-Oxoprolinuria associated with 5-oxoprolinase deficiency; further evidence that this is a benign disorder.

Authors:  M J Henderson; A Larsson; B Carlsson; P R Dear
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

8.  OXP1/YKL215c encodes an ATP-dependent 5-oxoprolinase in Saccharomyces cerevisiae: functional characterization, domain structure and identification of actin-like ATP-binding motifs in eukaryotic 5-oxoprolinases.

Authors:  Akhilesh Kumar; Anand Kumar Bachhawat
Journal:  FEMS Yeast Res       Date:  2010-03-10       Impact factor: 2.796

9.  5-oxoprolinuria due to hereditary 5-oxoprolinase deficiency in two brothers--a new inborn error of the gamma-glutamyl cycle.

Authors:  A Larsson; B Mattsson; E A Wauters; J D van Gool; M Duran; S K Wadman
Journal:  Acta Paediatr Scand       Date:  1981

Review 10.  Inborn errors in the metabolism of glutathione.

Authors:  Ellinor Ristoff; Agne Larsson
Journal:  Orphanet J Rare Dis       Date:  2007-03-30       Impact factor: 4.123

View more
  4 in total

1.  Transient 5-oxoprolinuria: unusually high anion gap acidosis in an infant.

Authors:  Sarah L Hulley; Jeff Perring; Nigel Manning; Simon Olpin; Sufin Yap
Journal:  Eur J Pediatr       Date:  2015-07-01       Impact factor: 3.183

2.  Characterization of the caprolactam degradation pathway in Pseudomonas jessenii using mass spectrometry-based proteomics.

Authors:  Marleen Otzen; Cyntia Palacio; Dick B Janssen
Journal:  Appl Microbiol Biotechnol       Date:  2018-05-31       Impact factor: 4.813

3.  A Multi-Biochemical and In Silico Study on Anti-Enzymatic Actions of Pyroglutamic Acid against PDE-5, ACE, and Urease Using Various Analytical Techniques: Unexplored Pharmacological Properties and Cytotoxicity Evaluation.

Authors:  Miroslava Šudomová; Sherif T S Hassan; Haroon Khan; Mahsa Rasekhian; Seyed Mohammad Nabavi
Journal:  Biomolecules       Date:  2019-08-21

Review 4.  Inborn errors of enzymes in glutamate metabolism.

Authors:  Lynne Rumping; Esmee Vringer; Roderick H J Houwen; Peter M van Hasselt; Judith J M Jans; Nanda M Verhoeven-Duif
Journal:  J Inherit Metab Dis       Date:  2019-10-11       Impact factor: 4.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.